NCT01880762
- Conditions
- Blood Protein Disorders, Bone Diseases, Bone Diseases, Metabolic, +19 more
- Locations
-
- NYU Center for Biomedical Imaging New York, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT00091624
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cleveland Clinic Myeloma Program Cleveland, Ohio, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
NCT00378209
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01122875
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Scottsdale, Arizona, United States
- Atlanta, Georgia, United States
- Chicago, Illinois, United States
- Boston, Massachusetts, United States
NCT01432353
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Scottsdale, Arizona, United States
- Duarte, California, United States
- Jacksonville, Florida, United States
- Sarasota, Florida, United States
NCT01804140
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Sedona, Arizona, United States
- Tucson, Arizona, United States
- Burbank, California, United States
- Rancho Cucamonga, California, United States
NCT02011113
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Celgene Trial Site Nagoya, Aichi-ken, Japan
- Celgene Trial Site Kamogawa, Chiba, Japan
- Celgene Trial Site Fukuoka, Japan
- Celgene Trial Site Hiroshima, Japan
Completed
Fungemia in Hematologic Malignancies
NCT02451592
- Conditions
- Acute Leukemia, Bacterial Infections and Mycoses, Blood Protein Disorders, +28 more
- Locations
-
- Catholic University of Sacred Heart Rome, Italy
Completed
Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients
NCT02471820
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- General Hospital of Athens "G. Gennimatas" Athens, Attica, Greece
- General Hospital of Athens "Alexandra" Athens, Attica, Greece
- University General Hospital of Patras Pátrai, Patra, Greece
- Theageneio Anticancer Hospital of Thessaloniki Thessaloniki, Greece